Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Vifor (International) AG

Home Clinical Trial Sponsors and OrganizationsVifor (International) AG

Vifor (International) AG

ACTIVE

Rechenstrasse 37, St. Gallen, Sankt Gallen, Switzerlandwww.vifor.comSubsidiary

Also known as:

vifor (international) inc.

Part of VIFOR PHARMA AG

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

97

82 active

Approvals

11

Total approvals

Agencies

3

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 1

32

33.0%

Phase 2

5

5.2%

Phase 3

2

2.1%

Phase 4

2

2.1%

Trial Status Distribution

Active, not recruiting

81

83.5%

Completed

13

13.4%

Not yet recruiting

1

1.0%

Withdrawn

2

2.1%

Clinical Trials

Trials sponsored by this organization (97)

Phase I trial: Fortrea code: 8476207

Oct 20238 participants

Cross-sectional Study to Assess Prevalence and Burden of CKD-associated Pruritus in Hemodialysis Patients

Cross-sectional Study to Assess Prevalence and Burden of CKD-associated Pruritus in Haemodialysis Patients

Feb 20233,100 participants

Phase I trial: Royal Infirmary Edinburgh Clinical Research Facility code: 003

Active, not recruiting

Oct 202290 participants

RAYALDEE Non Interventional Study (NIS) on Effectiveness in ND-CKD SHPT Patients

Oct 2022110 participants

A study to evaluate if VIT-2763 may be beneficial in the treatment of Nontransfusion Dependent Beta-thalassaemia.

May 202225 participants

Study to Assess Efficacy and Safety of VIT-2763 (Vamifeport) in Subjects With Sickle Cell Disease

Nov 202125 participants

Efficacy and Safety Study of Multiple Doses of VIT-2763 in Adults With Transfusion-dependent Beta-thalassaemia

Active, not recruiting

Page 1 of 13

Approvals

Approvals by Agency

NMPA

National Medical Products Administration

4

Approvals

FDA

Food and Drug Administration

6

Approvals

CANADA

Health Canada

1

Approvals

Recent Approvals

Iron Sucrose Injection

Ferric Carboxymaltose Injection

Ferric Carboxymaltose Injection

News

No news articles found

On this page

Overview
Clinical Trials97
Approvals11
News

Back to Organizations